Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryn Song

Showing results (141-150 of 161) with videos related to

Pageof 17
Sort By:
Investigative and Clinical Urology|August 1, 2020
The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinomaHyeong Dong Yuk, Minyong Kang, Eu Chang Hwang, et al.
Japanese Journal of Clinical Oncology|May 12, 2010
The efficacy and safety of sunitinib in korean patients with advanced renal cell carcinoma: high incidence of toxicity leads to frequent dose reductionChanghoon Yoo, Jeong Eun Kim, Jae-Lyun Lee, et al.
Scientific Reports|April 26, 2020
The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinomaHyeong Dong Yuk, Eu Chang Hwang, Jae Young Park, et al.
British Journal of Cancer|October 4, 2025
Distinct prognostic and molecular profiles of fat versus vein invasion in T3a renal cell carcinomaHyun Young Lee, Ray Raehun Lee, Yunlim Kim, et al.
Journal of Korean Medical Science|January 23, 2024
Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) DatabaseChangil Choi, Minyong Kang, Seong Il Seo, et al.
Clinical Genitourinary Cancer|May 28, 2017
Clinicopathologic Characteristics and Prognosis of Xp11.2 Translocation Renal Cell Carcinoma: Multicenter, Propensity Score Matching AnalysisMin Soo Choo, Chang Wook Jeong, Cheryn Song, et al.
Investigative and Clinical Urology|May 8, 2020
Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group databaseJae Young Park, Bum Sik Tae, Chang Wook Jeong, et al.
Human Pathology|December 20, 2016
Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinomaMyong Kim, Mooyoung Sohn, Myungsun Shim, et al.
Cancer Medicine|May 10, 2019
Survival and clinical prognostic factors in metastatic non-clear cell renal cell carcinoma treated with targeted therapy: A multi-institutional, retrospective study using the Korean metastatic renal cell carcinoma registryJung Kwon Kim, Sung Han Kim, Mi Kyung Song, et al.
Asian Journal of Urology|August 14, 2024
Optimal sequential therapy using tyrosine kinase inhibitors as the first-line treatment in patients with metastatic renal cell carcinoma: A nationwide multicenter studyJung Ki Jo, Seong Il Seo, MinYong Kang, et al.
Pageof 17

Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Investigative and Clinical Urology|August 1, 2020
The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinomaHyeong Dong Yuk, Minyong Kang, Eu Chang Hwang, et al.
Japanese Journal of Clinical Oncology|May 12, 2010
The efficacy and safety of sunitinib in korean patients with advanced renal cell carcinoma: high incidence of toxicity leads to frequent dose reductionChanghoon Yoo, Jeong Eun Kim, Jae-Lyun Lee, et al.
Scientific Reports|April 26, 2020
The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinomaHyeong Dong Yuk, Eu Chang Hwang, Jae Young Park, et al.
British Journal of Cancer|October 4, 2025
Distinct prognostic and molecular profiles of fat versus vein invasion in T3a renal cell carcinomaHyun Young Lee, Ray Raehun Lee, Yunlim Kim, et al.
Journal of Korean Medical Science|January 23, 2024
Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) DatabaseChangil Choi, Minyong Kang, Seong Il Seo, et al.
Clinical Genitourinary Cancer|May 28, 2017
Clinicopathologic Characteristics and Prognosis of Xp11.2 Translocation Renal Cell Carcinoma: Multicenter, Propensity Score Matching AnalysisMin Soo Choo, Chang Wook Jeong, Cheryn Song, et al.
Investigative and Clinical Urology|May 8, 2020
Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group databaseJae Young Park, Bum Sik Tae, Chang Wook Jeong, et al.
Human Pathology|December 20, 2016
Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinomaMyong Kim, Mooyoung Sohn, Myungsun Shim, et al.
Cancer Medicine|May 10, 2019
Survival and clinical prognostic factors in metastatic non-clear cell renal cell carcinoma treated with targeted therapy: A multi-institutional, retrospective study using the Korean metastatic renal cell carcinoma registryJung Kwon Kim, Sung Han Kim, Mi Kyung Song, et al.
Asian Journal of Urology|August 14, 2024
Optimal sequential therapy using tyrosine kinase inhibitors as the first-line treatment in patients with metastatic renal cell carcinoma: A nationwide multicenter studyJung Ki Jo, Seong Il Seo, MinYong Kang, et al.
Pageof 17